[HTML][HTML] The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

S Zhang, M Zhu, H Zhang, H Liu, X Fan, J Zhang, F Yu - Biomedicines, 2024 - mdpi.com
Lung metastasis substantially influences the survival of thyroid cancer (TC) patients. This
study sought to investigate factors impacting the survival of differentiated thyroid cancer …

[HTML][HTML] Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: an 8-year retrospective study

R Wang, Y Zhang, J Tan, G Zhang, R Zhang, W Zheng… - Medicine, 2017 - journals.lww.com
To assess the efficacy of radioiodine therapy (RIT) and investigate the prognostic factors for
patients with pulmonary metastasis secondary to differentiated thyroid carcinoma (DTC) …

Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan

N Akatani, H Wakabayashi, D Kayano, A Inaki… - Endocrine …, 2023 - jstage.jst.go.jp
Long-term survival in patients with differentiated thyroid cancer (DTC) and lung metastasis
remains unexplored in Japan. This study aimed to investigate the long-term survival and …

Radioactive iodine therapy in patients with thyroid carcinoma with distant metastases: a SEER-based study

C Li, Q Wu, S Sun - Cancer control, 2020 - journals.sagepub.com
Distant metastasis (DM) is the dominant negative prognosis for thyroid carcinoma.
Radioactive iodine (RAI) therapy serves as an effective treatment for thyroid carcinoma …

[HTML][HTML] Therapeutic response and long-term outcome of differentiated thyroid cancer with pulmonary metastases treated by radioiodine therapy

J Yang, M Liang, Y Jia, L Wang, L Lin, J Geng… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Objective To explore the therapeutic response (TR) and long-term outcomes of iodine-131 (I-
131) treatment for patients with differentiated thyroid cancer and pulmonary metastases …

[HTML][HTML] Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current …

X Zhang, DS Liu, ZS Luan, F Zhang, XH Liu… - Clinical and …, 2018 - Springer
Background Radioiodine therapy (RAI) after total or near-total thyroidectomy is a
recommended treatment for patients with pulmonary metastasis from differentiated thyroid …

Long-term outcomes of differentiated thyroid cancer with only lung metastasis and the prognostic factors

JH Choi, H Moon, J Park, K Chang, BH Byun, I Lim… - 2015 - Soc Nuclear Med
1260 Objectives The aim of this study was to investigate the long-term outcomes of only lung
metastasis in differentiated thyroid cancer (DTC) patients and the prognostic factors …

Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid …

F Pitoia, F Bueno, G Cross - Clinical Nuclear Medicine, 2014 - journals.lww.com
Long-Term Survival and Low Effective Cumulative Radioiodine... : Clinical Nuclear Medicine
Long-Term Survival and Low Effective Cumulative Radioiodine Doses to Achieve Remission in …

[HTML][HTML] Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed …

B Long, M Yang, Z Yang, H Yi, L Li - Oncology Letters, 2016 - spandidos-publications.com
Radioiodine therapy (RAI) has proven effective for the treatment of patients exhibiting
differentiated thyroid cancer (DTC) with pulmonary metastases. However, the early detection …

Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive …

ZL Qiu, CT Shen, QY Luo - Thyroid, 2015 - liebertpub.com
Background: Hyperfunctioning distant metastasis (HFDM) from differentiated thyroid cancer
(DTC) is a rare entity. This study aimed to assess the outcomes of DTC patients presenting …